Oro Therapeutics
- Biotech or pharma, therapeutic R&D
Developing peptide-drug conjugates (PDCs) to exploit the distinct enzymatic properties of cancer cells – offering hope to large populations not being served by immunotherapy-based treatments.
June 16-19, 2025
Boston Convention & Exhibition Center
Developing peptide-drug conjugates (PDCs) to exploit the distinct enzymatic properties of cancer cells – offering hope to large populations not being served by immunotherapy-based treatments.